United States Hemophilia Drugs Market Report 2016

United States Hemophilia Drugs Market Report 2016

1 Hemophilia Drugs Overview

1.1 Product Overview and Scope of Hemophilia Drugs

1.2 Classification of Hemophilia Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Hemophilia Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Hemophilia Drugs (2011-2021)

1.4.1 United States Hemophilia Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States Hemophilia Drugs Revenue and Growth Rate (2011-2021)

2 United States Hemophilia Drugs Competition by Manufacturers

2.1 United States Hemophilia Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Hemophilia Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Hemophilia Drugs Average Price by Manufactures (2015 and 2016)

2.4 Hemophilia Drugs Market Competitive Situation and Trends

2.4.1 Hemophilia Drugs Market Concentration Rate

2.4.2 Hemophilia Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Hemophilia Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Hemophilia Drugs Sales and Market Share by Type (2011-2016)

3.2 United States Hemophilia Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States Hemophilia Drugs Price by Type (2011-2016)

3.4 United States Hemophilia Drugs Sales Growth Rate by Type (2011-2016)

4 United States Hemophilia Drugs Sales (Volume) by Application (2011-2016)

4.1 United States Hemophilia Drugs Sales and Market Share by Application (2011-2016)

4.2 United States Hemophilia Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Hemophilia Drugs Manufacturers Profiles/Analysis

5.1 Baxalta

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Hemophilia Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Baxalta Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer

5.2.2 Hemophilia Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 CSL Behring

5.3.2 Hemophilia Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 CSL Behring Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Novo Nordisk

5.4.2 Hemophilia Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Novo Nordisk Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Pfizer

5.5.2 Hemophilia Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Pfizer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Roche

5.6.2 Hemophilia Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Roche Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Alnylam Pharmaceuticals

5.7.2 Hemophilia Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Alnylam Pharmaceuticals Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Amarna Therapeutics

5.8.2 Hemophilia Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Amarna Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Asklepios BioPharmaceutical

5.9.2 Hemophilia Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Asklepios BioPharmaceutical Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Biogen

5.10.2 Hemophilia Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Biogen Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 BioMarin

5.12 Catalyst Bioscience

5.13 Chiesi Farmaceutici

5.14 Dimension Therapeutics

5.15 Emergent BioSolutions

5.16 Grifols, Kedrion Biopharma

5.17 Octapharma

5.18 rEVO Biologics

5.19 OPKO Biologics

5.20 Sangamo Biosciences

5.21 Spark Therapeutics

5.22 Swedish Orphan Biovitrum

5.23 UniQure Biopharma.

6 Hemophilia Drugs Manufacturing Cost Analysis

6.1 Hemophilia Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Hemophilia Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Hemophilia Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Hemophilia Drugs Market Forecast (2016-2021)

10.1 United States Hemophilia Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States Hemophilia Drugs Sales Forecast by Type (2016-2021)

10.3 United States Hemophilia Drugs Sales Forecast by Application (2016-2021)

10.4 Hemophilia Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Hemophilia Drugs

Table Classification of Hemophilia Drugs

Figure United States Sales Market Share of Hemophilia Drugs by Type in 2015

Table Application of Hemophilia Drugs

Figure United States Sales Market Share of Hemophilia Drugs by Application in 2015

Figure United States Hemophilia Drugs Sales and Growth Rate (2011-2021)

Figure United States Hemophilia Drugs Revenue and Growth Rate (2011-2021)

Table United States Hemophilia Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Hemophilia Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Hemophilia Drugs Sales Share by Manufacturers

Figure 2016 Hemophilia Drugs Sales Share by Manufacturers

Table United States Hemophilia Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Hemophilia Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Hemophilia Drugs Revenue Share by Manufacturers

Table 2016 United States Hemophilia Drugs Revenue Share by Manufacturers

Table United States Market Hemophilia Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Hemophilia Drugs Average Price of Key Manufacturers in 2015

Figure Hemophilia Drugs Market Share of Top 3 Manufacturers

Figure Hemophilia Drugs Market Share of Top 5 Manufacturers

Table United States Hemophilia Drugs Sales by Type (2011-2016)

Table United States Hemophilia Drugs Sales Share by Type (2011-2016)

Figure United States Hemophilia Drugs Sales Market Share by Type in 2015

Table United States Hemophilia Drugs Revenue and Market Share by Type (2011-2016)

Table United States Hemophilia Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Hemophilia Drugs by Type (2011-2016)

Table United States Hemophilia Drugs Price by Type (2011-2016)

Figure United States Hemophilia Drugs Sales Growth Rate by Type (2011-2016)

Table United States Hemophilia Drugs Sales by Application (2011-2016)

Table United States Hemophilia Drugs Sales Market Share by Application (2011-2016)

Figure United States Hemophilia Drugs Sales Market Share by Application in 2015

Table United States Hemophilia Drugs Sales Growth Rate by Application (2011-2016)

Figure United States Hemophilia Drugs Sales Growth Rate by Application (2011-2016)

Table Baxalta Basic Information List

Table Baxalta Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Baxalta Hemophilia Drugs Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Hemophilia Drugs Sales Market Share (2011-2016)

Table CSL Behring Basic Information List

Table CSL Behring Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table CSL Behring Hemophilia Drugs Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Hemophilia Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Hemophilia Drugs Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Hemophilia Drugs Sales Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alnylam Pharmaceuticals Hemophilia Drugs Sales Market Share (2011-2016)

Table Amarna Therapeutics Basic Information List

Table Amarna Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amarna Therapeutics Hemophilia Drugs Sales Market Share (2011-2016)

Table Asklepios BioPharmaceutical Basic Information List

Table Asklepios BioPharmaceutical Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Asklepios BioPharmaceutical Hemophilia Drugs Sales Market Share (2011-2016)

Table Biogen Basic Information List

Table Biogen Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biogen Hemophilia Drugs Sales Market Share (2011-2016)

Table BioMarin Basic Information List

Table BioMarin Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table BioMarin Hemophilia Drugs Sales Market Share (2011-2016)

Table Catalyst Bioscience Basic Information List

Table Catalyst Bioscience Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Catalyst Bioscience Hemophilia Drugs Sales Market Share (2011-2016)

Table Chiesi Farmaceutici Basic Information List

Table Chiesi Farmaceutici Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chiesi Farmaceutici Hemophilia Drugs Sales Market Share (2011-2016)

Table Dimension Therapeutics Basic Information List

Table Dimension Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dimension Therapeutics Hemophilia Drugs Sales Market Share (2011-2016)

Table Emergent BioSolutions Basic Information List

Table Emergent BioSolutions Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Emergent BioSolutions Hemophilia Drugs Sales Market Share (2011-2016)

Table Grifols, Kedrion Biopharma Basic Information List

Table Grifols, Kedrion Biopharma Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Grifols, Kedrion Biopharma Hemophilia Drugs Sales Market Share (2011-2016)

Table Octapharma Basic Information List

Table Octapharma Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Octapharma Hemophilia Drugs Sales Market Share (2011-2016)

Table rEVO Biologics Basic Information List

Table rEVO Biologics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table rEVO Biologics Hemophilia Drugs Sales Market Share (2011-2016)

Table OPKO Biologics Basic Information List

Table OPKO Biologics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table OPKO Biologics Hemophilia Drugs Sales Market Share (2011-2016)

Table Sangamo Biosciences Basic Information List

Table Sangamo Biosciences Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sangamo Biosciences Hemophilia Drugs Sales Market Share (2011-2016)

Table Spark Therapeutics Basic Information List

Table Spark Therapeutics Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Spark Therapeutics Hemophilia Drugs Sales Market Share (2011-2016)

Table Swedish Orphan Biovitrum Basic Information List

Table Swedish Orphan Biovitrum Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Swedish Orphan Biovitrum Hemophilia Drugs Sales Market Share (2011-2016)

Table UniQure Biopharma. Basic Information List

Table UniQure Biopharma. Hemophilia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table UniQure Biopharma. Hemophilia Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Hemophilia Drugs

Figure Manufacturing Process Analysis of Hemophilia Drugs

Figure Hemophilia Drugs Industrial Chain Analysis

Table Raw Materials Sources of Hemophilia Drugs Major Manufacturers in 2015

Table Major Buyers of Hemophilia Drugs

Table Distributors/Traders List

Figure United States Hemophilia Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States Hemophilia Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States Hemophilia Drugs Production Forecast by Type (2016-2021)

Table United States Hemophilia Drugs Consumption Forecast by Application (2016-2021)